We encourage participation in collaborative research studies, both in academia and industry, for exciting new oportunities to develop and testing novel radiopharmaceuticals and drugs.

Screen Shot 2016-04-04 at 18.43.262
  • Selection of the best imaging modality to meet your research needs
  • Choice of appropriate animal model / strategies and SPECT acquisition parameters
  • Accurate selection of image acquisition and reconstruction parameters
Screen Shot 2016-04-04 at 18.43.38
  • Radiolabeling of small molecules, nanoparticles, small peptides, antibodies, polymers, microspheres, virus ...
  • Full characterization, stability studies, storage and distribution of radiopharmaceuticals
  • Guarantee of the shortest possible timing between synthesis and use in animal studies. Shipping and delivery to the CCM Facility
Screen Shot 2016-04-04 at 18.43.45
  • Small animal or phantom study modalities (design and preparation)
  • PET and SPECT data is calibrated for quantification in each study
  • Dual-Radionuclide Imaging: Simultaneous identification of PET/SPECT radioisotopes under same physiological conditions
Screen Shot 2016-04-04 at 18.43.56
  • Quantitative and qualitative imaging data: VOI-driven PET and SPECT analysis and determination of time activity curves (TACs)
  • Advanced analysis metrics such as spatial resolution, image contrast, and uniformity for your radioisotope
  • Elaboration of image analysis reports containing the conclusions obtained out of the imaging data
Screen Shot 2016-04-04 at 18.44.04
  • New to preclinical imaging? Do you have a novel SPECT/PET imaging idea but need preliminary data to apply for funding for a project?
  • Cost-effective pilot PET/SPECT studies (*) are aimed for proof-of-concept with minimal financial investment